Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75.9M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
22M
-
Shares change
-
+3.15M
-
Total reported value, excl. options
-
$387M
-
Value change
-
+$58.5M
-
Number of buys
-
21
-
Number of sells
-
-16
-
Price
-
$17.53
Significant Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q4 2020
49 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q4 2020.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22M shares
of 75.9M outstanding shares and own 29.05% of the company stock.
Largest 10 shareholders include BVF INC/IL (5.81M shares), FEDERATED HERMES, INC. (2.94M shares), BAKER BROS. ADVISORS LP (2.04M shares), Medicxi Ventures Management (Jersey) Ltd (1.6M shares), BOXER CAPITAL, LLC (1.43M shares), Sofinnova Investments, Inc. (1.31M shares), WELLINGTON MANAGEMENT GROUP LLP (1.22M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (744K shares), MPM ONCOLOGY IMPACT MANAGEMENT, L.P. (701K shares), and MPM Oncology Impact Management LP (701K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.